At a glance
- Originator Merck & Co
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action AMPA receptor antagonists; NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 07 Jan 2000 Discontinued-Preclinical for Epilepsy in USA (Unknown route)